ArticleBMJ open2022

Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients' satisfaction: a cross-sectional survey by patient organisations.

Kayoko Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.